Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px
All > Germany >

News > Southern Germany

Find below news from the Southhern German Federal States of Baden-Württemberg and Bayern (Bavaria). Listed are news about this region as well as from organisations located there.

Total search results: 2123 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Genedata AG. (11/12/19). "Press Release: Immatics Implements Genedata Biologics into Proprietary T-Cell Receptor Discovery and Engineering XCEPTOR Platform". Basel. 2019-11-12
4SC AG. (11/12/19). "Press Release: 4SC AG Secures circa EUR 22.4 Million from a Capital Increase [Not for release in US, Australia, Canada, et al.]". Planegg-Martinsried. 2019-11-12
SciRhom GmbH. (11/5/19). "Press Release: SciRhom Initiates First-In-Class Antibody Development Program to Treat Major Autoimmune Diseases". Munich. 2019-11-05
OpGen, Inc.. (10/28/19). "Press Release: OpGen Announces Closing of $9.4 Million Underwritten Public Offering". Gaithersburg, MD. 2019-10-28
MorphoSys AG. (10/28/19). "Press Release: MOR106 Clinical Development in Atopic Dermatitis Stopped for Futility". Planegg & Mechelen. 2019-10-28
OpGen, Inc.. (10/23/19). "Press Release: OpGen Announces Pricing of $9.4 Million Underwritten Offering". Gaithersburg, MD. 2019-10-23
Bluebird Bio, Inc.. (10/22/19). "Press Release: European Medicines Agency Approves Refined Commercial Manufacturing Specifications for Zynteglo". Cambridge, MA. 2019-10-22
MCG Motion Capture GmbH. (10/22/19). "Press Release: Motion Capture Group Retains Biotech Alliances International to Raise Series A $15 Million Financing Round". Heidelberg & San Francisco, CA. 2019-10-22
MorphoSys AG. (10/14/19). "Press Release: MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China". Planegg & Shanghai. 2019-10-14
iOmx Therapeutics AG. (10/9/19). "Press Release: iOmx Therapeutics Strengthens Executive Management Team and Supervisory Board". Martinsried. 2019-10-09
Rentschler Biopharma SE. (10/4/19). "Press Release: Rentschler Biopharma Announces Enhanced Collaboration with Summit Pharmaceuticals International Corporation to Expand Japanese Operation-Base". Laupheim & Milford, MA. 2019-10-04
Bruker Corporation. (10/2/19). "Press Release: Bruker Announces Acquisition of Magnettech’s EPR Business". Freiberg. 2019-10-02
MorphoSys AG. (9/16/19). "Press Release: MorphoSys's Licensee Janssen Submits Biologics License Application to U.S. FDA of Tremfya (Guselkumab) for Treatment of Adults with Active Psoriatic Arthritis". Planegg. 2019-09-16
Biocrates Life Sciences AG. (9/12/19). "Press Release: Repositioning of Biocrates – Management Change and New Round of Financing". Innsbruck. 2019-09-12
Curetis N.V.. (9/4/19). "Press Release: Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses". Gaithersburg, MD, Amsterdam & Holzgerlingen. 2019-09-04
Modag GmbH. (9/4/19). "Press Release: Modag Appoints Dr. Johannes Levin as Chief Medical Officer". Wendelsheim. 2019-09-04
Vivoryon Therapeutics AG. (8/29/19). "Press Release: Vivoryon Therapeutics Reports Financial Results for H1 2019 and Corporate Update". Halle (Saale). 2019-08-29
Immatics Biotechnologies GmbH. (8/28/19). "Press Release: Immatics and Celgene Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies". Houston, TX & Tübingen. 2019-08-28
Bruker Corporation. (8/25/19). "Press Release: Bruker Introduces Next-Generation 80 MHz Benchtop FT-NMR System". Berlin. 2019-08-25
High-Tech Gründerfonds Management GmbH. (8/8/19). "Press Release: Successful Exit for High-Tech Gründerfonds (HTGF) – HTGF sells Its Cytena Shares to Cellink in a Trade Sale". 2019-08-08
Curetis N.V.. (8/8/19). "Press Release: Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing". Vienna & Holzgerlingen. 2019-08-08
Expedeon AG. (8/6/19). "Press Release: Expedeon AG Signs Commercial Agreement with Sona Nanotech". Halifax, Heidelberg & Cambridge. 2019-08-06
Inveox GmbH. (8/5/19). "Press Release: 17 Million for Future Cancer Diagnoses. Inveox Acquires Further Investment". Munich. 2019-08-05
GNA Biosolutions GmbH. (8/5/19). "Press Release: GNA Biosolutions Closes $13.5M Series C Financing Round Backed by a US/EU consortium". Munich. 2019-08-05
Cytena GmbH. (8/5/19). "Press Release: Cytena GmbH Announces that It Has Been Entered into an Agreement to Be Acquired by Cellink". Freiburg. 2019-08-05
Imcyse. (8/5/19). "Press Release: Imcyse Announces Changes in Management and Board, Appoints Thomas Taapken as Executive Chairman". Liège. 2019-08-05
ExpreS2ion Biotech Holding AB. (8/2/19). "Press Release: ExpreS2ion’s Licensee Institut Virion\Serion Launches the First in Vitro Diagnostic Product Based on the ExpreS2-platform". 2019-08-02
Sirion Biotech GmbH. (7/31/19). "Press Release: Gene and Cell Therapy Solutions Provider, Sirion Biotech Announces Record First Half 2019 Financial Results". Munich. 2019-07-31
Wellington Partners. (7/31/19). "Press Release: Wellington Partners Raises EUR 210 Million Life Science Fund". 2019-07-31
Cytena GmbH. (7/23/19). "Press Release: Cytena Founds Subsidiary in Taiwan". Freiburg. 2019-07-23
Vasopharm GmbH. (7/11/19). "Press Release: Vasopharm Closes € 9.5 Million Financing Round". 2019-07-11
MorphoSys AG. (7/8/19). "Press Release: MorphoSys and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibitors of CD47-SIRP alpha Signaling in Immuno-Oncology". Planegg & Halle (Saale). 2019-07-08
Bruker Corporation. (7/8/19). "Press Release: Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies LLC". Zurich. 2019-07-08
Immatics Biotechnologies GmbH. (7/8/19). "Press Release: Immatics Appoints Harpreet Singh as Chief Executive Officer". Tübingen & Houston, TX. 2019-07-08
GlaxoSmithKline plc. (7/3/19). "Press Release: GSK Announces Phase III Start for Its anti GM-CSF Antibody, Otilimab, in Patients with Rheumatoid Arthritis (RA)". London. 2019-07-03
MorphoSys AG. (7/3/19). "Press Release: MorphoSys' Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilimab (MOR103/GSK3196165) in Rheumatoid Arthritis; MorphoSys Updates its Financial Guidance for 2019". Planegg. 2019-07-03
R-Biopharm AG. (7/1/19). "Press Release: Distribution of the New Innovative Molecular Diagnostics Platform Vivalytic Starts". Darmstadt. 2019-07-01
4SC AG. (6/28/19). "Press Release: 4SC AG Secures EUR 11 Million from Capital Increase [Ad hoc, not for US, AU, CA, JP, ZA, et al.]". Planegg-Martinsried. 2019-06-28
Velabs Therapeutics GmbH. (6/27/19). "Press Release: Velabs Therapeutics Announces €3 Million Series B Financing to Advance its Functional Antibody Screening Programme". Heidelberg. 2019-06-27
Vesalius Biocapital Partners Sàrl. (6/25/19). "Press Release: Vesalius Biocapital III Announces Final Close of EUR 120 Million Fund". Strassen, Luxembourg. 2019-06-25
MorphoSys AG. (6/24/19). "Press Release: MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Executive Officer". Planegg. 2019-06-24
InflaRx N.V.. (6/5/19). "Press Release: InflaRx Announces Top-Line SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa". Jena. 2019-06-05
Spindiag GmbH. (6/4/19). "Press Release: Spindiag’s Continued Road to Success. Expansion of Series A with an additional 4 Million Euros for Market Entry". Freiburg. 2019-06-04
Labfolder GmbH. (5/22/19). "Press Release: Lab Notebook Learns to Communicate with Laboratory Devices. Labfolder Acquires Cubuslab and Becomes Labforward". Berlin & Karlsruhe. 2019-05-22
Affimed N.V.. (5/22/19). "Press Release: Affimed Announces R&D Strategy to Focus on Innate Immunity Portfolio, Reports First Quarter 2019 Financial Results and Operational Progress". Heidelberg. 2019-05-22
MorphoSys AG. (5/16/19). "Press Release: Primary Endpoint of L-MIND, a Combination Study of Tafasitamab (MOR208) and Lenalidomide, Has Been MMet, Confirming Previously Published Activity". Planegg. 2019-05-16
MCG Motion Capture GmbH. (5/15/19). "Press Release: MCG Motion Capture GmbH Founded by Seasoned Medtech and Digital Health Entrepreneurs". Heidelberg & Potsdam. 2019-05-15
Progen Biotechnik GmbH. (5/15/19). "Press Release: Progen Biotechnik GmbH Now With New Joint Leadership". Heidelberg. 2019-05-15
Medigene AG. (5/14/19). "Press Release: Medigene Reports Financial & Business Results for the First Three Months of 2019". Martinsried. 2019-05-14
Roche Diagnostics GmbH. (5/10/19). "Pressemitteilung: Neuer Geschäftsführer Personal bei der Roche Diagnostics GmbH. Mit Wirkung zum 1. Juni 2019 folgt Andreas Schmitz auf Edgar Vieth". Mannheim & Penzberg. 2019-05-10
Medigene AG. (5/9/19). "Press Release: Bluebird Presents Preclinical Data of First TCR Candidate from Medigene Collaboration. Start Clinical Development 2020". Martinsried. 2019-05-09
MorphoSys AG. (5/7/19). "Press Release: MorphoSys AG Reports First Quarter 2019 Results". Planegg. 2019-05-07
Confo Therapeutics N.V.. (5/7/19). "Press Release: Confo Therapeutics Raises €30 Million in Series A Financing". Ghent. 2019-05-07
Medigene AG. (5/2/19). "Press Release: Medigene Presented Data on Favorable Safety Pattern of PRAME-specific TCR on Neuronal Cells at 2019 ASGCT Meeting". Martinsried. 2019-05-02
Velabs Therapeutics GmbH. (4/24/19). "Press Release: Velabs Therapeutics to Cooperate with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening". Heidelberg. 2019-04-24
MorphoSys AG. (4/23/19). "Press Release: MorphoSys and Galapagos Announce Initiation of GECKO Phase 2 Study with MOR106 in Atopic Dermatitis Patients". Planegg & Mechelen. 2019-04-23
Affimed N.V.. (4/17/19). "Press Release: Affimed Provides Regulatory Update on AFM11 Clinical Program". Heidelberg. 2019-04-17
Immunic, Inc.. (4/12/19). "Press Release: Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases". San Diego, CA & Martinsried. 2019-04-12
Curetis N.V.. (4/11/19). "Press Release: Curetis Publishes Full-Year 2018 Financial Results and Updated Guidance for 2019". Amsterdam & Holzgerlingen. 2019-04-11
Protagen Protein Services GmbH. (4/10/19). "Press Release: Protagen Protein Services and BioAnalytix Merge to Create Global Analytic Service Partner for Biopharmaceuticals". Heilbronn & Boston, MA. 2019-04-10
Bruker Corporation. (4/9/19). "Press Release: DKSH and Bruker AXS Strengthen Partnership in China". Shanghai. 2019-04-09
Phenex Pharmaceuticals AG. (4/5/19). "Press Release: Phenex Collaborates with Mathias Heikenwälder’s Research Group from DKFZ (German Cancer Research Center)". Ludwigshafen. 2019-04-05
Medigene AG. (4/4/19). "Press Release: Roivant and Sinovant Launch Cytovant Sciences in Partnership with Medigene to Develop Cellular Therapies in Asia". Martinsried & Hong Kong. 2019-04-04
Curetis N.V.. (4/4/19). "Press Release: Study Data Presented at ECCMID 2019 Confirm Clinical Benefits of Unyvero Platform". Amsterdam, San Diego, CA & Holzgerlingen. 2019-04-04
ERS Genomics Ltd.. (4/3/19). "Press Release: European Patent Office Grants 3rd Charpentier/Doudna Patent Covering Uses of CRISPR/cas9 in Human and Animal Cells". Dublin. 2019-04-03
Novartis AG. (4/3/19). "Press Release: Sandoz Resubmits Biosimilar Pegfilgrastim Application to US FDA". Holzkirchen. 2019-04-03
Immunic AG. (4/2/19). "Press Release: Immunic Therapeutics to Present at the Needham Healthcare Conference on April 10". Planegg-Martinsried. 2019-04-02
Inveox GmbH. (4/2/19). "Press Release: Innovation Across Borders. Inveox Expands to Poland". Garching & Kraków. 2019-04-02
Affimed N.V.. (4/1/19). "Press Release: Affimed Highlights AFM24 Innate Cell Engager Novel Mechanism of Action and Potential for the Treatment of EGFR-expressing Solid Tumors at the American Association for Cancer Research (AACR) 2019 Annual Meeting". He 2019-04-01
MorphoSys AG. (4/1/19). "Press Release: Dr. Sarah Fakih Joins MorphoSys as Head of Corporate Communications and Investor Relations". Planegg. 2019-04-01
Cytena GmbH. (3/26/19). "Press Release: EUR 3 Million in Series A for the Growth and Development of Cytena GmbH". 2019-03-26
4SC AG. (3/20/19). "Press Release: 4SC AG Provides Results for Financial Year 2018 and Outlook". Planegg-Martinsried. 2019-03-20
Affimed N.V.. (3/19/19). "Press Release: Affimed Announces Milestone Payment from Genentech and ROCK Platform Presentation at Innate Killer Summit 2019, Further Highlighting Leadership in Innate Immunity". Heidelberg. 2019-03-19
Bruker Corporation. (3/14/19). "Press Release: Bruker Announces Acquisition of Scientific Software Provider Arxspan". Billerica, MA. 2019-03-14
MorphoSys AG. (3/13/19). "Press Release: MorphoSys Presents Results for Fiscal Year 2018". Planegg. 2019-03-13
Snipr Biome ApS. (3/11/19). "Press Release: Snipr Biome Raises $50 Million Series A Financing to Advance CRISPR-based Microbiome Drugs to Human Clinical Trials". Copenhagen. 2019-03-11
MorphoSys AG. (3/7/19). "Press Release: MorphoSys Provides Updates on L-MIND and B-MIND Clinical Trials of MOR208 in Relapsed/Refractory DLBCL". Planegg. 2019-03-07
Enzymicals AG. (3/4/19). "Press Release: abcr GmbH and Enzymicals AG Deepen the Cooperation". Greifswald & Karlsruhe. 2019-03-04
CureVac AG. (2/27/19). "Press Release: CEPI Awards US$ 34m Contract to CureVac to Advance the RNA Printer—a Disruptive, Transportable mRNA Vaccine Manufacturing Platform that Can Rapidly Combat Multiple Diseases". Oslo. 2019-02-27
MorphoSys AG. (2/27/19). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Received U.S. FDA Approval for Tremfya One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis". Planegg. 2019-02-27
Medigene AG. (2/25/19). "Press Release: European Patent Covering TCR Library Suitable for the Development of Neoantigen-specific TCRs". Martinsried. 2019-02-25
Eppendorf AG. (2/21/19). "Press Release: Thomas Heydler Appointed to the Supervisory Board of Eppendorf AG". Hamburg. 2019-02-21
HeiScreen GmbH. (2/21/19). "Press Release: Researchers at Heidelberg University Hospital Develop First Marketable Blood Test for Breast Cancer". Düsseldorf & Heidelberg. 2019-02-21
MorphoSys AG. (2/19/19). "Press Release: Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire". Planegg. 2019-02-19
BioMed X GmbH. (2/14/19). "Press Release: Merck and BioMed X Expand Collaboration to Immunology Research". Heidelberg. 2019-02-14
High-Tech Gründerfonds Management GmbH. (2/14/19). "Press Release: Plasmion’ SICRIT Sensor Technology Convinces Investors". 2019-02-14
Medigene AG. (2/11/19). "Press Release: Medigene Appoints Axel-Sven Malkomes as CFO/CBDO". Martinsried. 2019-02-11
InflaRx N.V.. (2/6/19). "Press Release: InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena. 2019-02-06
4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. 2019-02-06
CureVac AG. (2/4/19). "Press Release: CureVac Appoints Stefan Mueller, Ph.D., as Vice President Preclinical". Tübingen & Boston, MA. 2019-02-04
Apceth Biopharma GmbH. (1/31/19). "Press Release: Hitachi Chemical Co. Ltd. to Acquire Apceth Biopharma GmbH". Munich. 2019-01-31
Hitachi Chemical Co., Ltd.. (1/31/19). "Press Release: Notice Regarding the Stock Acquisition of Apceth Biopharma GmbH, a Contract Manufacturer of Regenerative Medicine Products". 2019-01-31
MorphoSys AG. (1/31/19). "Press Release: MorphoSys Announces Settlement in Patent Lawsuit with Janssen and Genmab". Planegg. 2019-01-31
MorphoSys AG. (1/26/19). "Press Release: MorphoSys Announces That Its Patents Were Ruled Invalid in Patent Lawsuit Against Janssen and Genmab (Ad hoc)". Planegg. 2019-01-26
Genmab A/S. (1/26/19). "Press Release: Genmab Announces that the Patents Asserted against Darzalex in the United States Have Been Declared Invalid by Summary Judgment". Copenhagen. 2019-01-26
BioNTech AG. (1/23/19). "Press Release: BioNTech to Acquire Antibody Generation Unit of MAB Discovery". Mainz & Munich. 2019-01-23
Kurma Partners. (1/21/19). "Press Release: Kurma Partners Sees Great Opportunities for Early-stage Biotech Investments in Germany and Launches Operations in Munich". Paris & Munich. 2019-01-21
Bruker Corporation. (1/18/19). "Press Release: Bruker Launches the G6 Leonardo for Oxygen, Nitrogen and Hydrogen (ONH) Analysis by Inert Gas Fusion". Delhi. 2019-01-18
MorphoSys AG. (1/17/19). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Expanded Clinical Development of Guselkumab (Tremfya) into Ulcerative Colitis". Planegg. 2019-01-17
BioMed X GmbH. (1/17/19). "Press Release: BioMed X and Boehringer Ingelheim to Investigate Early Intervention in Psychiatric Diseases". Heidelberg. 2019-01-17
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22  next pagenext page



Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px

» top